FIV in cats - a useful model of HIV in people?

Veterinary Immunology and Immunopathology

Volumn 159, Issue 3-4, 2014, Pages 171-179

  Bienzle, Dorothee ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

AIDS; CXCR4; Feline; Immunodeficiency; Lentivirus; Retrovirus

Indexed keywords

ADEFOVIR; ATAZANAVIR; EXPORTIN 1; GENOMIC RNA; HOST FACTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LOPINAVIR; PLERIXAFOR; TIPRANAVIR;

ADAPTIVE IMMUNITY; ARTICLE; CAT; CELLULAR IMMUNITY; FELINE IMMUNODEFICIENCY VIRUS; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; NONHUMAN; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; STRUCTURAL GENE; TROPISM; VIRUS REPLICATION; ANIMAL; CAT DISEASE; DISEASE MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; LENTIVIRUS INFECTION; PHYSIOLOGY; VETERINARY; VIROLOGY;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

ANIMALS; CAT DISEASES; CATS; DISEASE MODELS, ANIMAL; HIV; HIV INFECTIONS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS INFECTIONS; VIRUS REPLICATION;

EID: 84900515217     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2014.02.014     Document Type: Article

References (104)

1. Achleitner A., Clark M.E., Bienzle D. T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1). Vet. Immunol. Immunopathol. 2011, 143:307-313.
2. Ackley C.D., Yamamoto J.K., Levy N., Pedersen N.C., Cooper M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 1990, 64:5652-5655.
3. Ammersbach M., Bienzle D. Methods for assessing feline immunodeficiency virus infection, infectivity and purification. Vet. Immunol. Immunopathol. 2011, 143:202-214.
4. Arts E.J., Hazuda D.J. HIV-1 antiretroviral drug therapy. Cold Spring Harb. Perspect. Med. 2012, 2:a007161.
5. Bande F., Arshad S.S., Hassan L., Zakaria Z., Sapian N.A., Rahman N.A., Alazawy A. Prevalence and risk factors of feline leukaemia virus and feline immunodeficiency virus in peninsular Malaysia. BMC Vet. Res. 2012, 8:33.
6. Bonci F., Zabogli E., Conti F., Merico A., Freer G., Bendinelli M., Pistello M. A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts. BMC Biotechnol. 2009, 9:18.
7. Celestino M., Calistri A., Del Vecchio C., Salata C., Chiuppesi F., Pistello M., Borsetti A., Palù G., Parolin C. Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein. J. Virol. 2012, 86:6688-6700.
8. Chhetri B.K., Berke O., Pearl D.L., Bienzle D. Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000-2011). BMC Vet. Res. 2013, 9:2.
9. Coats K.S., Boudreaux C.E., Clay B.T., Lockett N.N., Scott V.L. Placental immunopathology in the FIV-infected cat: a role for inflammation in compromised pregnancy?. Vet. Immunol. Immunopathol. 2010, 134:39-47.
10. Coffin J., Swanstrom R. HIV pathogenesis: dynamics and genetics of viral populations and infected cells. Cold Spring Harb. Perspect. Med. 2013, 3:1-17.
11. Dean G.A., LaVoy A., Yearley J., Stanton C. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats. J. Infect. Dis. 2006, 193:1520-1527.
12. Dietrich I., Hosie M.J., Willett B.J. The role of BST2/tetherin in feline retrovirus infection. Vet. Immunol. Immunopathol. 2011, 143:255-264.
13. Dietrich I., Macintyre A., McMonagle E., Price A.J., James L.C., McEwan W.A., Hosie M.J., Willett B.J. Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. J. Virol. 2010, 84:8980-8985.
14. Dunham S.P., Bruce J., MacKay S., Golder M., Jarrett O., Neil J.C. Limited efficacy of an inactivated feline immunodeficiency virus vaccine. Vet. Rec. 2006, 158:561-562.
15. Elder J.H., Lin Y.C., Fink E., Grant C.K. Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr. HIV Res. 2010, 8:73-80.
16. Elder J.H., Sundstrom M., de Rozieres S., de Parseval A., Grant C.K., Lin Y.C. Molecular mechanisms of FIV infection.Vet Immunol Immunopathol. Vet Immunol Immunopathol. 2008, 123:3-13.
17. Fadel H.J., Saenz D.T., Poeschla E.M. Construction and testing of orfA +/- FIV reporter viruses. Viruses 2012, 4:184-198.
18. Flynn J.N., Dunham S., Mueller A., Cannon C., Jarrett O. Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2002, 85:159-170.
19. Fogle J.E., Mexas A.M., Tompkins W.A., Tompkins M.B. CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism. AIDS Res. Hum. Retroviruses 2010, 26:201-216.
20. Fogle J.E., Tompkins W.A., Tompkins M.B. CD4+CD25+ T regulatory cells from FIV+ cats induce a unique anergic profile in CD8+ lymphocyte targets. Retrovirology 2010, 7:97.
21. Fogle J.E., Tompkins W.A., Campbell B., Sumner D., Tompkins M.B. Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection. J. Vet. Intern. Med. 2011, 25:413-418.
22. Folkl A., Wen X., Kuczynski E., Clark M.E., Bienzle D. Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2010, 134:107-114.
23. Fukuma A., Abe M., Morikawa Y., Miyazawa T., Yasuda J. Cloning and characterization of the antiviral activity of feline tetherin/BST-2. PLoS One 2011, 6:e18247.
24. Gabor L.J., Love D.N., Malik R., Canfield P.J. Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Aust. Vet. J. 2001, 79:540-545.
25. Gramberg T., Kahle T., Bloch N., Wittmann S., Müllers E., Daddacha W., Hofmann H., Kim B., Lindemann D., Landau N.R. Restriction of diverse retroviruses by SAMHD1. Retrovirology 2013, 10:26.
26. Grant C.K., Fink E.A., Sundstrom M., Torbett B.E., Elder J.H. Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19980-19985.
27. Hahn B.H., Shaw G.M., De Cock K.M., Sharp P.M. AIDS as a zoonosis: scientific and public health implications. Science 2000, 287:607-614.
28. Harari A., Pantaleo G. HIV-1-specific immune response. Adv. Pharmacol. 2008, 56:75-92.
29. Hartmann K. Clinical aspects of feline retroviruses: a review. Viruses 2012, 4:2684-2710.
30. Hofmann-Lehmann R., Berger M., Sigrist B., Schawalder P., Lutz H. Feline immunodeficiency virus (FIV) infection leads to increased incidence of feline odontoclastic resorptive lesions (FORL). Vet. Immunol. Immunopathol. 1998, 65:299-308.
31. Hofmann-Lehmann R., Holznagel E., Ossent P., Lutz H. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin. Diagn. Lab. Immunol. 1997, 4:33-42.
32. Hong Y., Fink E., Hu Q.Y., Kiosses W.B., Elder J.H. OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection. J. Virol. 2010, 84:7225-7232.
33. Hosie M.J., Pajek D., Samman A., Willett B.J. Feline immunodeficiency virus (FIV) neutralization: a review. Viruses 2011, 3:1870-1890.
34. Howard K.E., Reckling S.K., Egan E.A., Dean G.A. Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology 2010, 7:2.
35. Hu Q.Y., Fink E., Hong Y., Wang C., Grant C.K., Elder J.H. Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein. PLoS One 2010, 5:e10689.
36. Iwasaki A. Innate immune recognition of HIV-1. Immunity 2012, 37:389-398.
37. Justa N., Weber K., Klein D., Mueller R.S., Sauter-Louis C., Hartmann K. Efficacy and adverse effects of (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine in feline immunodeficiency virus-infected cats. J. Vet. Intern. Med. 2012, 26:1267-1273.
38. Kemler I., Saenz D., Poeschla E. Feline immunodeficiency virus Gag is a nuclear shuttling protein. J. Virol. 2012, 86:8402-8411.
39. Kraase M., Sloan R., Klein D., Logan N., McMonagle L., Biek R., Willett B.J., Hosie M.J. Feline immunodeficiency virus env gene evolution in experimentally infected cats. Vet. Immunol. Immunopathol. 2010, 134:96-106.
40. Lee I.T., Levy J.K., Gorman S.P., Crawford P.C., Slater M.R. Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats. J. Am. Vet. Med. Assoc. 2002, 220:620-622.
41. Lehman T.L., O'Halloran K.P., Fallon S.A., Habermann L.M., Campbell J.A., Nordone S., Dean G.A., Hoover E.A., Avery P.R. Altered bone marrow dendritic cell cytokine production to toll-like receptor and CD40 ligation during chronic feline immunodeficiency virus infection. Immunology 2009, 126:405-412.
42. Lerner D.L., Wagaman P.C., Phillips T.R., Prospero-Garcia O., Henriksen S.J., Fox H.S., Bloom F.E., Elder J.H. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7480-7484.
43. Li Z., Phadke A., Weaver E.A., Ball J.M., Collisson E.W. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors. Dev. Comp. Immunol. 2005, 29:809-824.
44. Lin Y.C., Perryman A.L., Olson A.J., Torbett B.E., Elder J.H., Stout C.D. Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease. Acta. Crystallogr. D Biol. Crystallogr. 2011, 67:540-548.
45. Maingat F., Viappiani S., Zhu Y., Vivithanaporn P., Ellestad K.K., Holden J., Silva C., Power C. Regulation of lentivirus neurovirulence by lipopolysaccharide conditioning: suppression of CXCL10 in the brain by IL-10. J. Immunol. 2010, 184:1566-1574.
46. Maksaereekul S., Dubie R.A., Shen X., Kieu H., Dean G.A., Sparger E.E. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV. Vaccine 2009, 27:3754-3765.
47. McCarthy M. Large US study of HIV vaccine is halted because of lack of efficacy. BMJ 2013, 346:f2734.
48. McDermott A.B., Koup R.A. CD8(+) T cells in preventing HIV infection and disease. AIDS 2012, 26:1281-1292.
49. McEwan W.A., McMonagle E.L., Logan N., Serra R.C., Kat P., Vandewoude S., Hosie M.J., Willett B.J. Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. J. Virol. 2008, 82:10953-10958.
50. McEwan W.A., Schaller T., Ylinen L.M., Hosie M.J., Towers G.J., Willett B.J. Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J. Virol. 2009, 83:8270-8275.
51. Meeker R.B., Bragg D.C., Poulton W., Hudson L. Transmigration of macrophages across the choroid plexus epithelium in response to the feline immunodeficiency virus. Cell Tissue Res. 2012, 347:443-455.
52. Miller C., Bielefeldt-Ohmann H., MacMillan M., Huitron-Resendiz S., Henriksen S., Elder J., VandeWoude S. Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. Vet. Immunol. Immunopathol. 2011, 143:282-291.
53. Miller M.M., Fogle J.E., Ross P., Tompkins M.B. Feline glycoprotein a repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency. AIDS Res. Hum. Retroviruses 2013, 29:641-651.
54. Mohammadi H., Bienzle D. Pharmacological inhibition of feline immunodeficiency virus (FIV). Viruses. 2012, 4:708-724.
55. Nakagaki K., Nakagaki K., Takahashi K., Schols D., De Clercq E., Tabira T. CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes. J. Neurovirol. 2001, 7:487-492.
56. Norelli S., El Daker S., D'Ostilio D., Mele F., Mancini F., Taglia F., Ruggieri A., Ciccozzi M., Cauda R., Ciervo A., Barreca M.L., Pistello M., Bendinelli M., Savarino A. Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1. Curr. HIV Res. 2008, 6:306-317.
57. O'Brien S.J., Troyer J.L., Brown M.A., Johnson W.E., Antunes A., Roelke M.E., Pecon-Slattery J. Emerging viruses in the felidae: shifting paradigms. Viruses 2012, 4:236-257.
58. de Parseval A., Chatterji U., Morris G., Sun P., Olson A.J., Elder J.H. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat. Struct. Mol. Biol. 2005, 12:60-66.
59. de Parseval A., Chatterji U., Sun P., Elder J.H. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13044-13049.
60. Pecon-Slattery J., McCracken C.L., Troyer J.L., VandeWoude S., Roelke M., Sondgeroth K., Winterbach C., Winterbach H., O'Brien S.J. Genomic organization, sequence divergence, and recombination of feline immunodeficiency virus from lions in the wild. BMC Genomics 2008, 9:66.
61. Peeters M., Delaporte E. Simian retroviruses in African apes. Clin. Microbiol. Infect. 2012, 18:514-520.
62. Poli A., Tozon N., Guidi G., Pistello M. Renal alterations in feline immunodeficiency virus (FIV)-infected cats: a natural model of lentivirus-induced renal disease changes. Viruses 2012, 4:1372-1389.
63. Poss M., Ross H., Rodrigo A., Terwee J., Vandewoude S., Biek R. The molecular biology and evolution of feline immunodeficiency viruses of cougars. Vet. Immunol. Immunopathol. 2008, 123:154-158.
64. Pu R., Coleman J., Omori M., Arai M., Hohdatsu T., Huang C., Tanabe T., Yamamoto J.K. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 2001, 15:1225-1237.
65. Reggeti F., Bienzle D. Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol. 2004, 85:1843-1852.
66. Reggeti F., Ackerley C., Bienzle D. CD134 and CXCR4 expression corresponds to feline immunodeficiency virus infection of lymphocytes, macrophages and dendritic cells. J. Gen. Virol. 2008, 89:277-287.
67. Robert-Tissot C., Rüegger V.L., Cattori V., Meli M.L., Riond B., Gomes-Keller M.A., Vögtlin A., Wittig B., Juhls C., Hofmann-Lehmann R., Lutz H. The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation. Vet. Immunol. Immunopathol. 2011, 143:269-281.
68. Roelke M.E., Brown M.A., Troyer J.L., Winterbach H., Winterbach C., Hemson G., Smith D., Johnson R.C., Pecon-Slattery J., Roca A.L., Alexander K.A., Klein L., Martelli P., Krishnasamy K., O'Brien S.J. Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology 2009, 390:1-12.
69. de Rozìeres S., Thompson J., Sundstrom M., Gruber J., Stump D.S., de Parseval A.P., VandeWoude S., Elder J.H. Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat. J. Virol. 2008, 82:7953-7963.
70. Rudicell R.S., Holland Jones J., Wroblewski E.E., Learn G.H., Li Y., Robertson J.D., Greengrass E., Grossmann F., Kamenya S., Pintea L., Mjungu D.C., Lonsdorf E.V., Mosser A., Lehman C., Collins D.A., Keele B.F., Goodall J., Hahn B.H., Pusey A.E., Wilson M.L. Impact of simian immunodeficiency virus infection on chimpanzee population dynamics. PLoS Pathog. 2010, 6:e1001116.
71. Saenz D.T., Barraza R., Loewen N., Teo W., Poeschla E.M. Feline immunodeficiency virus-based lentiviral vectors. Cold Spring Harb. Protoc. 2012, 2012:71-76.
72. Samman A., Logan N., McMonagle E.L., Ishida T., Mochizuki M., Willett B.J., Hosie M.J. Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env. J. Gen. Virol. 2010, 91:242-249.
73. Santos S., Obukhov Y., Nekhai S., Bukrinsky M., Iordanskiy S. Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 2012, 9:65.
74. Saunders K.O., Ward-Caviness C., Schutte R.J., Freel S.A., Overman R.G., Thielman N.M., Cunningham C.K., Kepler T.B., Tomaras G.D. Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cell Immunol. 2011, 266:154-164.
75. Savarino A., Pistello M., D'Ostilio D., Zabogli E., Taglia F., Mancini F., Ferro S., Matteucci D., De Luca L., Barreca M.L., Ciervo A., Chimirri A., Ciccozzi M., Bendinelli M. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS. Retrovirology 2007, 4:79.
76. Schaller T., Ylinen L.M., Webb B.L., Singh S., Towers G.J. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses. J. Virol. 2007, 81:10055-10063.
77. Scott V.L., Boudreaux C.E., Lockett N.N., Clay B.T., Coats K.S. Cytokine dysregulation in early- and late-term placentas from feline immunodeficiency virus (FIV)-infected cats. Am. J. Reprod. Immunol. 2011, 65:480-491.
78. Scott V.L., Burgess S.C., Shack L.A., Lockett N.N., Coats K.S. Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats. Vet. Immunol. Immunopathol. 2008, 123:90-96.
79. Sharp P.M., Hahn B.H. Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med. 2011, 1:1-22.
80. Shen X., Leutenegger C.M., Stefano Cole K., Pedersen N.C., Sparger E.E. A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens. J. Gen. Virol. 2007, 88:2793-2799.
81. Shimojima M., Miyazawa T., Ikeda Y., McMonagle E.L., Haining H., Akashi H., Takeuchi Y., Hosie M.J., Willett B.J. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 2004, 303:1192-1195.
82. Siebelink K.H., Tijhaar E., Huisman R.C., Huisman W., de Ronde A., Darby I.H., Francis M.J., Rimmelzwaan G.F., Osterhaus A.D. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 1995, 69:3704-3711.
83. Simões R.D., Howard K.E., Dean G.A. In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infection. PLoS One 2012, 7:e37606.
84. Sprague W.S., TerWee J.A., VandeWoude S. Temporal association of large granular lymphocytosis, neutropenia, proviral load, and FasL mRNA in cats with acute feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2010, 134:115-121.
85. Stoeker L.L., Overman E.L., Nordone S.K., Moeser A.J., Simões R.D., Dean G.A. Infection with feline immunodeficiency virus alters intestinal epithelial transport and mucosal immune responses to probiotics. Vet. Immunol. Immunopathol. 2013, 153:146-152.
86. Takehisa J., Kraus M.H., Ayouba A., Bailes E., Van Heuverswyn F., Decker J.M., Li Y., Rudicell R.S., Learn G.H., Neel C., Ngole E.M., Shaw G.M., Peeters M., Sharp P.M., Hahn B.H. Origin and biology of simian immunodeficiency virus in wild-living western gorillas. J. Virol. 2009, 83:1635-1648.
87. Teixeira B.M., Hagiwara M.K., Cruz J.C., Hosie M.J. Feline immunodeficiency virus in South America. Viruses 2012, 4:383-396.
88. Terwee J.A., Yactor J.K., Sondgeroth K.S., Vandewoude S. Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity. J. Virol. 2005, 79:2797-2806.
89. Tompkins M.B., Tompkins W.A. Lentivirus-induced immune dysregulation. Vet. Immunol. Immunopathol. 2008, 123:45-55.
90. Tompkins M.B., Bull M.E., Dow J.L., Ball J.M., Collisson E.W., Winslow B.J., Phadke A.P., Vahlenkamp T.W., Tompkins W.A. Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis. J. Infect. Dis. 2002, 185:1077-1093.
91. Troth S.P., Dean A.D., Hoover E.A. In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2008, 123:97-105.
92. Troyer J.L., Vandewoude S., Pecon-Slattery J., McIntosh C., Franklin S., Antunes A., Johnson W., O'Brien S.J. FIV cross-species transmission: an evolutionary prospective. Vet. Immunol. Immunopathol. 2008, 123:159-166.
93. Vahlenkamp T.W., Tompkins M.B., Tompkins W.A. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells. J. Immunol. 2004, 172:4752-4761.
94. Walker B., McMichael A. The T-cell response to HIV. Cold Spring Harb. Perspect. Med. 2012, 2.
95. Wang J., Zhang W., Lv M., Zuo T., Kong W., Yu X. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins. J. Virol. 2011, 85:12482-12491.
96. Weaver E.A. A detailed phylogenetic analysis of FIV in the United States. PLoS One 2010, 5:e12004.
97. Willett B.J., Hosie M.J. Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection. Vet Immunol Immunopathol 2008, 123:56-64.
98. White T.E., Brandariz-Nuñez A., Carlos Valle-Casuso J., Amie S., Nguyen L., Kim B., Brojatsch J., Diaz-Griffero F. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 2013, 436:81-90.
99. Wongsrikeao P., Saenz D., Rinkoski T., Otoi T., Poeschla E. Antiviral restriction factor transgenesis in the domestic cat. Nat. Methods 2011, 8:853-859.
100. Yamamoto J.K., Ackley C.D., Zochlinski H., Louie H., Pembroke E., Torten M., Hansen H., Munn R., Okuda T. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology 1991, 32:361-375.
101. Yamamoto J.K., Sanou M.P., Abbott J.R., Coleman J.K. Feline immunodeficiency virus model for designing HIV/AIDS vaccines. Curr. HIV Res. 2010, 8:14-25.
102. Yang X., Jiao Y.M., Wang R., Ji Y.X., Zhang H.W., Zhang Y.H., Chen D.X., Zhang T., Wu H. High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression. PLoS One 2012, 7:e49526.
103. Zhang M.Y., Yuan T., Li J., Rosa Borges A., Watkins J.D., Guenaga J., Yang Z., Wang Y., Wilson R., Li Y., Polonis V.R., Pincus S.H., Ruprecht R.M., Dimitrov D.S. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41. PLoS One 2012, 7:e44241.
104. Zielonka J., Münk C. Cellular restriction factors of feline immunodeficiency virus. Viruses 2011, 3:1986-2005.